Current neurology and neuroscience reports · 2024
CGRP Modulating Therapies: An Update.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bedrin Kate, Shah Tulsi, Vaidya Shivani, Ailani Jessica
Аннотация
INTRODUCTION: Calcitonin-gene related peptide (CGRP) is a vasoactive neuropeptide involved in the pathophysiology ofmigraine. CGRP has been targeted for both preventive and acute treatment of migraine.
OBJECTIVE: Provide a summary of the most clinically relevant literature surrounding CGRP modulating therapies.
METHODS: This update on CGRP modulating therapies includes articles selected as most clinically relevant by theauthors.
CONCLUSION: CGRP modulating therapies are an exciting new addition to migraine treatment given their safety andtolerability. Additionally, compared to traditional migraine preventive medication these treatments are migrainespecific.Further real-world and clinical data is ongoing to better understand these treatments that continue to gainfavor in the management of migraine.
OBJECTIVE: Provide a summary of the most clinically relevant literature surrounding CGRP modulating therapies.
METHODS: This update on CGRP modulating therapies includes articles selected as most clinically relevant by theauthors.
CONCLUSION: CGRP modulating therapies are an exciting new addition to migraine treatment given their safety andtolerability. Additionally, compared to traditional migraine preventive medication these treatments are migrainespecific.Further real-world and clinical data is ongoing to better understand these treatments that continue to gainfavor in the management of migraine.